BF844 Safety and Pharmacokinetic Study in Healthy Volunteers
Status:
NOT_YET_RECRUITING
Trial end date:
2025-09-06
Target enrollment:
Participant gender:
Summary
First-in-Human Phase-1 Clinical Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Ascending Doses of BF844 when Administered Orally to Healthy Adult Participants.